Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

[Rheumatology reflected in art].

Aeschlimann AG, Aeschlimann FA, Michel BA.

Z Rheumatol. 2018 May;77(4):274-281. doi: 10.1007/s00393-018-0462-1. Review. German. No abstract available.

PMID:
29691691
2.

TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles.

Frank-Bertoncelj M, Pisetsky DS, Kolling C, Michel BA, Gay RE, Jüngel A, Gay S.

Front Immunol. 2018 Jan 29;9:28. doi: 10.3389/fimmu.2018.00028. eCollection 2018.

3.

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC.

JCI Insight. 2017 Nov 16;2(22). pii: 92724. doi: 10.1172/jci.insight.92724. eCollection 2017 Nov 16.

4.

Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions.

Frank-Bertoncelj M, Trenkmann M, Klein K, Karouzakis E, Rehrauer H, Bratus A, Kolling C, Armaka M, Filer A, Michel BA, Gay RE, Buckley CD, Kollias G, Gay S, Ospelt C.

Nat Commun. 2017 Mar 23;8:14852. doi: 10.1038/ncomms14852.

5.

Interdisciplinary rehabilitation after whiplash injury: An observational prospective 5 years outcome study.

Haiduk P, Benz T, Lehmann S, Gysi-Klaus F, Aeschlimann A, Michel BA, Angst F.

Medicine (Baltimore). 2017 Mar;96(9):e6113. doi: 10.1097/MD.0000000000006113.

6.

Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis.

Pleštilová L, Neidhart M, Russo G, Frank-Bertoncelj M, Ospelt C, Ciurea A, Kolling C, Gay RE, Michel BA, Vencovský J, Gay S, Jüngel A.

PLoS One. 2016 Nov 28;11(11):e0166920. doi: 10.1371/journal.pone.0166920. eCollection 2016.

7.

MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts.

Gaur N, Karouzakis E, Glück S, Bagdonas E, Jüngel A, Michel BA, Gay RE, Gay S, Frank-Bertoncelj M, Neidhart M.

RMD Open. 2016 Oct 14;2(2):e000299. eCollection 2016.

8.

AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts.

Kato M, Ospelt C, Kolling C, Shimizu T, Kono M, Yasuda S, Michel BA, Gay RE, Gay S, Klein K, Atsumi T.

Oncotarget. 2016 Sep 27;7(39):64221-64232. doi: 10.18632/oncotarget.11890.

9.

Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.

Aradi B, Kato M, Filkova M, Karouzakis E, Klein K, Scharl M, Kolling C, Michel BA, Gay RE, Buzas EI, Gay S, Jüngel A.

Arthritis Rheumatol. 2015 Oct;67(10):2624-33. doi: 10.1002/art.39256.

10.

Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets.

von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS.

Eur Neurol. 2015;73(3-4):238-46. doi: 10.1159/000377675. Epub 2015 Mar 25. Review.

11.

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.

Ciurea A, Scherer A, Weber U, Exer P, Bernhard J, Tamborrini G, Riek M, Müller RB, Weiss B, Nissen MJ, Kissling R, Michel BA, Finckh A; Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis.

Ann Rheum Dis. 2016 Mar;75(3):532-9. doi: 10.1136/annrheumdis-2013-205133. Epub 2015 Feb 9.

PMID:
25667205
12.

The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists.

Boehncke WH, Anliker MD, Conrad C, Dudler J, Hasler F, Hasler P, Häusermann P, Kyburz D, Laffitte E, Michel BA, Möller B, Navarini AA, Villiger PM, Yawalkar N, Gabay C.

Dermatology. 2015;230(1):75-81. doi: 10.1159/000367688. Epub 2015 Jan 6.

13.

Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.

Ciurea A, Weber U, Stekhoven D, Scherer A, Tamborrini G, Bernhard J, Toniolo M, Villiger PM, Zufferey P, Kissling RO, Michel BA, Exer P; Rheumatologists of Swiss Clinical Quality Management.

J Rheumatol. 2015 Jan;42(1):101-5. doi: 10.3899/jrheum.140229. Epub 2014 Nov 1.

PMID:
25362654
14.

Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts.

Karouzakis E, Trenkmann M, Gay RE, Michel BA, Gay S, Neidhart M.

J Immunol. 2014 Nov 15;193(10):4945-51. doi: 10.4049/jimmunol.1400066. Epub 2014 Oct 15.

15.

Computer-based diagnostic expert systems in rheumatology: where do we stand in 2014?

Alder H, Michel BA, Marx C, Tamborrini G, Langenegger T, Bruehlmann P, Steurer J, Wildi LM.

Int J Rheumatol. 2014;2014:672714. doi: 10.1155/2014/672714. Epub 2014 Jul 8. Review.

16.

Age at symptom onset in ankylosing spondylitis: is there a gender difference?

Ciurea A, Scherer A, Weber U, Neuenschwander R, Tamborrini G, Exer P, Bernhard J, Villiger PM, Kissling R, Michel BA, Stekhoven D; rheumatologists of the Swiss Clinical Quality Management Program for axial spondyloarthritis.

Ann Rheum Dis. 2014 Oct;73(10):1908-10. doi: 10.1136/annrheumdis-2014-205613. Epub 2014 Aug 7. No abstract available.

PMID:
25104774
17.

Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.

Maurer B, Graf N, Michel BA, Müller-Ladner U, Czirják L, Denton CP, Tyndall A, Metzig C, Lanius V, Khanna D, Distler O; EUSTAR co-authors.

Ann Rheum Dis. 2015 Jun;74(6):1124-31. doi: 10.1136/annrheumdis-2014-205226. Epub 2014 Jun 30.

PMID:
24981642
18.

Multidimensional associative factors for improvement in pain, function, and working capacity after rehabilitation of whiplash associated disorder: a prognostic, prospective outcome study.

Angst F, Gantenbein AR, Lehmann S, Gysi-Klaus F, Aeschlimann A, Michel BA, Hegemann F.

BMC Musculoskelet Disord. 2014 Apr 16;15:130. doi: 10.1186/1471-2474-15-130. Erratum in: BMC Musculoskelet Disord. 2014;15:195.

19.

Smoking induces transcription of the heat shock protein system in the joints.

Ospelt C, Camici GG, Engler A, Kolling C, Vogetseder A, Gay RE, Michel BA, Gay S.

Ann Rheum Dis. 2014 Jul;73(7):1423-6. doi: 10.1136/annrheumdis-2013-204486. Epub 2014 Feb 18.

PMID:
24550170
20.

Relevant baseline characteristics for describing patients with knee osteoarthritis: results from a Delphi survey.

Wildi LM, Hensel A, Wertli M, Michel BA, Steurer J.

BMC Musculoskelet Disord. 2013 Dec 30;14:369. doi: 10.1186/1471-2474-14-369.

21.

Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors.

Maurer B, Distler A, Dees C, Khan K, Denton CP, Abraham D, Gay RE, Michel BA, Gay S, Hw Distler J, Distler O.

Ann Rheum Dis. 2013 Dec;72(12):2039-46. doi: 10.1136/annrheumdis-2013-203729. Epub 2013 Sep 7.

PMID:
24013728
22.

[Back pain].

Michel BA.

Ther Umsch. 2013 Sep;70(9):501. doi: 10.1024/0040-5930/a000437. German. No abstract available.

PMID:
23985146
23.

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.

Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis.

Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.

24.

Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.

Maurer B, Distler A, Suliman YA, Gay RE, Michel BA, Gay S, Distler JH, Distler O.

Ann Rheum Dis. 2014 Oct;73(10):1880-7. doi: 10.1136/annrheumdis-2013-203535. Epub 2013 Aug 5.

PMID:
23918036
25.

Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis.

Filková M, Aradi B, Senolt L, Ospelt C, Vettori S, Mann H, Filer A, Raza K, Buckley CD, Snow M, Vencovský J, Pavelka K, Michel BA, Gay RE, Gay S, Jüngel A.

Ann Rheum Dis. 2014 Oct;73(10):1898-904. doi: 10.1136/annrheumdis-2012-202815. Epub 2013 Jul 29.

26.

Prognostic factors for pain relief and functional improvement in chronic pain after inpatient rehabilitation.

Fuss I, Angst F, Lehmann S, Michel BA, Aeschlimann A.

Clin J Pain. 2014 Apr;30(4):279-85. doi: 10.1097/AJP.0b013e31829a4d11.

27.

Estimating prion adsorption capacity of soil by BioAssay of Subtracted Infectivity from Complex Solutions (BASICS).

Wyckoff AC, Lockwood KL, Meyerett-Reid C, Michel BA, Bender H, VerCauteren KC, Zabel MD.

PLoS One. 2013;8(3):e58630. doi: 10.1371/journal.pone.0058630. Epub 2013 Mar 4.

28.

Tumor necrosis factor α-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-κB signaling.

Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, Huber LC.

Arthritis Rheum. 2013 Apr;65(4):916-27. doi: 10.1002/art.37834.

29.

Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts.

Sanchez-Pernaute O, Filkova M, Gabucio A, Klein M, Maciejewska-Rodrigues H, Ospelt C, Brentano F, Michel BA, Gay RE, Herrero-Beaumont G, Gay S, Neidhart M, Juengel A.

Ann Rheum Dis. 2013 Aug;72(8):1400-6. doi: 10.1136/annrheumdis-2012-201906. Epub 2012 Dec 12.

PMID:
23234648
30.

BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment.

Niederer F, Scherer A, Kyburz D, Gay RE, Gay S, Michel BA, Ciurea A.

Joint Bone Spine. 2013 Jul;80(4):433-4. doi: 10.1016/j.jbspin.2012.10.004. Epub 2012 Nov 16. No abstract available.

31.

High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI.

Fischer DR, Pfirrmann CW, Zubler V, Stumpe KD, Seifert B, Strobel K, Tamborrini G, von Schulthess GK, Michel BA, Ciurea A.

EJNMMI Res. 2012 Jul 12;2(1):38. doi: 10.1186/2191-219X-2-38.

32.

Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.

Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, Michel BA, Gay S, Distler JH, Distler O.

Ann Rheum Dis. 2012 Aug;71(8):1382-7. doi: 10.1136/annrheumdis-2011-200940. Epub 2012 Apr 20.

33.

DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts.

Karouzakis E, Rengel Y, Jüngel A, Kolling C, Gay RE, Michel BA, Tak PP, Gay S, Neidhart M, Ospelt C.

Genes Immun. 2011 Dec;12(8):643-52. doi: 10.1038/gene.2011.45. Epub 2011 Jul 14.

34.

[Comment on rule of thumb 14. Polymyalgia].

Michel BA.

Praxis (Bern 1994). 2011 Jun 8;100(12):705-6. doi: 10.1024/1661-8157/a000562. German. No abstract available.

PMID:
21656497
35.

Biologics in rheumatoid arthritis--recommendations for Swiss practice.

Dudler J, Möller B, Michel BA, Villiger PM.

Swiss Med Wkly. 2011 May 10;141:w13189. doi: 10.4414/smw.2011.13189. eCollection 2011.

36.

Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis.

Trenkmann M, Brock M, Gay RE, Kolling C, Speich R, Michel BA, Gay S, Huber LC.

Ann Rheum Dis. 2011 Aug;70(8):1482-8. doi: 10.1136/ard.2010.143040. Epub 2011 Apr 22.

37.

[Web-based learning in musculoskeletal ultrasound].

Tamborrini G, Krebs A, Michel M, Michel BA, Ciurea A.

Z Rheumatol. 2011 Feb;70(2):154-9. doi: 10.1007/s00393-010-0740-z. German.

38.

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.

Kyburz D, Gabay C, Michel BA, Finckh A; physicians of SCQM-RA.

Rheumatology (Oxford). 2011 Jun;50(6):1106-10. doi: 10.1093/rheumatology/keq424. Epub 2011 Jan 21.

39.

Monitoring immune cells trafficking fluorescent prion rods hours after intraperitoneal infection.

Johnson TE, Michel BA, Meyerett C, Duffy A, Avery A, Dow S, Zabel MD.

J Vis Exp. 2010 Nov 19;(45). pii: 2349. doi: 10.3791/2349.

40.

Glucosamine and osteoarthritis. Effect size is encouraging.

Pelletier JP, Hochberg MC, du Souich P, Kahan A, Michel BA.

BMJ. 2010 Nov 9;341:c6328. doi: 10.1136/bmj.c6328. No abstract available.

PMID:
21062884
41.

Mixed crystal-induced arthropathy--a rare finding.

Tamborrini G, Distler O, Schmet M, Michel BA.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5):801. Epub 2010 Oct 22. No abstract available.

PMID:
21029566
42.

18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis.

Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, Johayem A, von Schulthess GK, Michel BA, Ciurea A.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1760-5. doi: 10.1007/s00259-010-1464-7. Epub 2010 May 27.

43.

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.

Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O.

Arthritis Rheum. 2010 Jun;62(6):1733-43. doi: 10.1002/art.27443.

44.

Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.

Ospelt C, Mertens JC, Jüngel A, Brentano F, Maciejewska-Rodriguez H, Huber LC, Hemmatazad H, Wüest T, Knuth A, Gay RE, Michel BA, Gay S, Renner C, Bauer S.

Arthritis Rheum. 2010 May;62(5):1224-35. doi: 10.1002/art.27395.

45.

Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression.

Maciejewska-Rodrigues H, Karouzakis E, Strietholt S, Hemmatazad H, Neidhart M, Ospelt C, Gay RE, Michel BA, Pap T, Gay S, Jüngel A.

J Autoimmun. 2010 Aug;35(1):15-22. doi: 10.1016/j.jaut.2009.12.010. Epub 2010 Jan 15.

46.

Functional autoantibodies against serpin E2 in rheumatoid arthritis.

Maciejewska-Rodrigues H, Al-Shamisi M, Hemmatazad H, Ospelt C, Bouton MC, Jäger D, Cope AP, Charles P, Plant D, Distler JH, Gay RE, Michel BA, Knuth A, Neidhart M, Gay S, Jüngel A.

Arthritis Rheum. 2010 Jan;62(1):93-104. doi: 10.1002/art.25038.

47.

Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis.

Kurowska-Stolarska M, Distler JH, Jüngel A, Rudnicka W, Neumann E, Pap T, Wenger RH, Michel BA, Müller-Ladner U, Gay RE, Maslinski W, Gay S, Distler O.

Arthritis Rheum. 2009 Dec;60(12):3663-75. doi: 10.1002/art.25001.

48.

DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.

Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M.

Arthritis Rheum. 2009 Dec;60(12):3613-22. doi: 10.1002/art.25018.

49.

Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.

Maurer B, Busch N, Jüngel A, Pileckyte M, Gay RE, Michel BA, Schett G, Gay S, Distler J, Distler O.

Circulation. 2009 Dec 8;120(23):2367-76. doi: 10.1161/CIRCULATIONAHA.109.855114. Epub 2009 Nov 23.

50.

[Chronic musculo-skeletal pain in Switzerland: patient care from the view of physicians and patients].

Michel BA, Tschumi U, Woolf AD, Zeidler H, Beglinger Ch, Dalvit G, Felder M, Graf A, Steurer J; Arthritis Action Group Switzerland.

Praxis (Bern 1994). 2009 Aug 26;98(17):933-40. doi: 10.1024/1661-8157.98.17.933. German.

PMID:
19711286

Supplemental Content

Loading ...
Support Center